DE69326347T2 - Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt - Google Patents

Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt

Info

Publication number
DE69326347T2
DE69326347T2 DE69326347T DE69326347T DE69326347T2 DE 69326347 T2 DE69326347 T2 DE 69326347T2 DE 69326347 T DE69326347 T DE 69326347T DE 69326347 T DE69326347 T DE 69326347T DE 69326347 T2 DE69326347 T2 DE 69326347T2
Authority
DE
Germany
Prior art keywords
binding
vap
molecule
mediates
endothelcell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69326347T
Other languages
English (en)
Other versions
DE69326347D1 (de
Inventor
Sirpa Jalkanen
Marko Salmi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotie Therapies Corp
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25404388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69326347(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Publication of DE69326347D1 publication Critical patent/DE69326347D1/de
Application granted granted Critical
Publication of DE69326347T2 publication Critical patent/DE69326347T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69326347T 1992-06-09 1993-06-09 Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt Expired - Lifetime DE69326347T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89535492A 1992-06-09 1992-06-09
PCT/FI1993/000250 WO1993025582A1 (en) 1992-06-09 1993-06-09 A novel endothelial cell molecule mediating lymphocyte binding in man

Publications (2)

Publication Number Publication Date
DE69326347D1 DE69326347D1 (de) 1999-10-14
DE69326347T2 true DE69326347T2 (de) 2000-02-24

Family

ID=25404388

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326347T Expired - Lifetime DE69326347T2 (de) 1992-06-09 1993-06-09 Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt

Country Status (14)

Country Link
EP (1) EP0656906B1 (de)
JP (2) JP3431922B2 (de)
KR (1) KR100268772B1 (de)
AT (1) ATE184315T1 (de)
AU (1) AU671837B2 (de)
CA (1) CA2137551C (de)
DE (1) DE69326347T2 (de)
DK (1) DK0656906T3 (de)
ES (1) ES2135480T3 (de)
FI (1) FI121176B (de)
GR (1) GR3031255T3 (de)
HU (1) HU217175B (de)
NZ (2) NZ299958A (de)
WO (1) WO1993025582A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2204838C2 (ru) * 1997-05-23 2003-05-20 Байотай Терапис Лтд. Сосудистый белок - 1 адгезии, обладающий аминооксидазной активностью
FI20020807A0 (fi) * 2002-04-29 2002-04-29 Biotie Therapies Oyj Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
FI20061156A0 (fi) 2006-12-27 2006-12-27 Elina Kivi Uusia peptidejä
FI20075278A0 (fi) * 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69406664T2 (de) * 1993-06-18 1998-06-04 Biotie Therapies Oy Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6

Also Published As

Publication number Publication date
DE69326347D1 (de) 1999-10-14
KR100268772B1 (ko) 2000-10-16
NZ299958A (en) 2000-07-28
JPH07507557A (ja) 1995-08-24
AU4328193A (en) 1994-01-04
EP0656906B1 (de) 1999-09-08
NZ253151A (en) 1997-03-24
KR950701938A (ko) 1995-05-17
FI121176B (fi) 2010-08-13
HU9403516D0 (en) 1995-02-28
WO1993025582A1 (en) 1993-12-23
AU671837B2 (en) 1996-09-12
FI20095269A (fi) 2009-03-16
GR3031255T3 (en) 1999-12-31
JP2003180346A (ja) 2003-07-02
EP0656906A1 (de) 1995-06-14
JP3500384B2 (ja) 2004-02-23
HUT75824A (en) 1997-05-28
CA2137551C (en) 2002-03-26
JP3431922B2 (ja) 2003-07-28
DK0656906T3 (da) 1999-12-20
ES2135480T3 (es) 1999-11-01
HU217175B (hu) 1999-12-28
ATE184315T1 (de) 1999-09-15
CA2137551A1 (en) 1993-12-23

Similar Documents

Publication Publication Date Title
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
HK1044159A1 (zh) 抗γ-干擾素的人化抗體
DE69429095T2 (de) Humanisierte antikoerper
KR950700779A (ko) 단백질의 정제방법(Protein purification)
TNSN93012A1 (fr) Conception, clonage et expression d'anticorps monoclonaux humanises contre l'interleukine-5 humaine
DE69636748D1 (de) Bispezifischer antikörper zur effektiven behandlung von b-zell lymphomen und zellinien
NO982062L (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
ES2079638T3 (es) Anticuerpos humanizados.
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
ATE218387T1 (de) Antikörperreinigung
ATE137533T1 (de) Monoklonale antikörper gegen melanom
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
NO922621L (no) Farmasoeytiske preparater inneholdende antigen-antistoffkomplekser og anvendelser derav
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
WO1992004464A3 (en) Monoclonal antibodies against tenascin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition